James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Why Boeing Co (BA), Paychex, Inc. (PAYX) and Valeant Pharmaceuticals Intl Inc (VRX) Are 3 of Today’s Worst Stocks

Boeing (BA), Paychex (PAYX) and Valeant Pharmaceuticals (VRX) were suspiciously left out of the rally on Wednesday.

Berkshire Hathaway Inc.: UBS Is Making BRK a Hero for the Wrong Reasons

Berkshire Hathaway (BRK) is a pretty obvious play right now -- but that doesn't necessarily make it a bad play.

Why Baker Hughes Incorporated (BHI), Fifth Third Bancorp (FITB) and Medivation Inc (MDVN) Are 3 of Today’s Worst Stocks

Hughes Incorporated (BHI), Fifth Third Bancorp (FITB) and Medivation Inc (MDVN) all ended Tuesday's session with notable losses.

Could SunEdison Inc Be Delisted? (SUNE)

SunEdison (SUNE) shares are in proverbial quicksand .... the longer they struggle, the more trouble they find themselves in.

Yahoo! Inc. (YHOO): Take Whatever Offer You Get

One way or another, the Yahoo saga is close to an end. Unfortunately, compared to two years ago, all of the endings are relatively ugly.